Dr. Scott Rocklage

Dr. Scott Rocklage studied Chemistry at the University of California. He later enrolled his Ph.D. at the Massachusetts Institute of Technology where he graduated with a Doctorate Degree.

 

Scott Rocklage joined his 5AM Ventures, where he currently works, in the year 2003. When he joined, Scott Rocklage was tasked with the role of a Venture Partner. He later scaled up to become the Managing Partner in the year 2004.

 

Dr. Scott Rocklage boasts more over two decades expertise that he has earned while serving in the healthcare industry. He also has extensive skills in the leadership responsibilities in various fields.

 

In the past, Dr. Scott Rocklage worked as the Chief Executive Officer and the Chairman of Cubist Pharmaceuticals, Chairman and Chief Executive Officer of Nycomed Interventional. Dr. Scott also served as the Chief Executive Officer and President of Nycomed Salutar. He also held several R&D posts at Catalytica and Salutar.

 

Dr. Scott has positions in the Boards of various bodies such as Relypsa, Semprus, and Achaogen. In the three mentioned organizations, Scott serves as the Chairman of the Boards. His broad experience makes him a resource in the field of healthcare and entrepreneurship.

 

Expansion Therapeutics conducted a funds drive to collect money to help them in fighting expansion repeat disorders. One of the disorder that Expansion Therapeutics took a keen concern on was myotonic dystrophy type I. The disease develops when the production of RNA reaches some toxic levels inside the cell. 5AM Ventures was among the companies that participated in the funding of the project.

 

Other companies that participated in the project funding are Novartis Venture Fund, Sanofi Ventures. Alexandria Venture Investments was one the companies that funded the project. RA Capital Management also financed the program.

 

The condition of myotonic dystrophy type I occurs when the production of RNA, the molecular elements that are transferred from DNA and transformed into proteins, reaches toxic levels.

 

Dr. Scott likes sharing his ideas with other experts such as physicians, scientists or entrepreneurs. He argues that a shared idea is halfway implemented. His ideas majorly revolve around medical care. He helps healthcare specialists to come up with medical treatment strategies and drugs that cure unmet illnesses. Learn more: https://www.crunchbase.com/person/scott-m-rocklage